Stay updated with breaking news from Registration Pathway. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DEA extends COVID-19 era rules allowing healthcare providers to prescribe certain controlled substances via telehealth through 2024, to give time to patients wh
On-track to activate first US clinical trial sites in on-going pivotal phase III global registration study, NANORAY-312, in locally advanced head and neck squamous cell carcinoma (LA-HNSCC) in Q3
On-track to activate first US clinical trial sites in on-going pivotal phase III global registration study, NANORAY-312, in locally advanced head and neck squamous cell carcinoma (LA-HNSCC) in Q3
18.05.2022 - Regulatory News: NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the 'Company'), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced operational ... Seite 1